- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有24家主力机构披露2025-12-31报告期持股数据，持仓量总计7181.01万股，占流通A股4.65%
- 波段诊断：
-
技术面诊股
诊断结果：8.2技术面打败了93%的股票
技术面评分前10的股票
近期的平均成本为19.87元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为19.87元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"19.87","date":1772008098,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2026.02.26","stock":"-0.65","trade":"-0.81","ind":"-0.01"},{"date":"2026.02.25","stock":"2.79","trade":"0.87","ind":"0.72"},{"date":"2026.02.24","stock":"0.83","trade":"0.55","ind":"0.87"},{"date":"2026.02.13","stock":"1.43","trade":"-0.79","ind":"-1.26"},{"date":"2026.02.12","stock":"-0.16","trade":"-1.10","ind":"0.05"},{"date":"2026.02.11","stock":"0.26","trade":"-0.46","ind":"0.09"},{"date":"2026.02.10","stock":"-1.41","trade":"0.52","ind":"0.13"},{"date":"2026.02.09","stock":"-0.52","trade":"0.67","ind":"1.41"},{"date":"2026.02.06","stock":"0.26","trade":"0.56","ind":"-0.25"},{"date":"2026.02.05","stock":"1.10","trade":"0.23","ind":"-0.64"},{"date":"2026.02.04","stock":"3.65","trade":"0.76","ind":"0.85"},{"date":"2026.02.03","stock":"0.88","trade":"1.56","ind":"1.29"},{"date":"2026.02.02","stock":"-1.03","trade":"-2.55","ind":"-2.48"},{"date":"2026.01.30","stock":"1.10","trade":"-0.63","ind":"-0.96"},{"date":"2026.01.29","stock":"0.17","trade":"-0.82","ind":"0.16"},{"date":"2026.01.28","stock":"-0.27","trade":"-1.60","ind":"0.27"},{"date":"2026.01.27","stock":"-0.55","trade":"-1.34","ind":"0.18"},{"date":"2026.01.26","stock":"0.33","trade":"0.66","ind":"-0.09"},{"date":"2026.01.23","stock":"-0.22","trade":"1.43","ind":"0.33"},{"date":"2026.01.22","stock":"0.22","trade":"-0.07","ind":"0.14"},{"date":"2026.01.21","stock":"-0.44","trade":"0.37","ind":"0.08"}]
ST人福,上证指数,化学制药指数
压力支撑
该股压力位为19.87元，支撑位为19.67元。
[{"text":"\u538b\u529b\u4f4d","value":"19.87","date":1772035200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"19.67","date":1772035200,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.2资金面打败了42%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：02月26日 20:31
| 机构今日流向(万元) | -3278.63 | 机构5日流向(万元) | -6736.35 |
| 机构10日流向(万元) | -6376.25 | 机构20日流向(万元) | -19711.53 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少67749.17万股，其中基金净减仓5家，主力净减仓464家，请投资者中长期谨慎为宜。
截止2025-12-31，共24家主力机构（基金24家），持仓量总计7181.01万股，占流通A股4.65%
其中，基金持仓与2025-06-30相比：
增仓：6家 ，增持 61.68万股
减仓：11家 ，减持 1321.84万股
新出现在主力名单中：5家 ，持有152.54万股
从主力名单中消失：469家 ，原持有66641.55万股
其中，基金持仓与2025-06-30相比：
增仓：6家 ，增持 61.68万股
减仓：11家 ，减持 1321.84万股
新出现在主力名单中：5家 ，持有152.54万股
从主力名单中消失：469家 ，原持有66641.55万股
消息面诊股
诊断结果：5.3消息面打败了50%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 募资35亿：搞新药，搞数值智化的特色药企
2026-02-26 - 人福医药拟定增募资不超35亿元 推进四大项目加码创
2026-02-26 - 30亿-35亿，人福医药发力了
2026-02-25 - "麻醉药龙头"再“补血”
2026-02-25 - 麻醉药龙头向央企大股东募资，定增价格引质疑
2026-02-25 - ST人福拟向控股股东不超35亿定增 去年实控人变国
2026-02-25 - 2026年02月25日早间个股预警：ST人福拟向控
2026-02-25 - ST人福：拟定增募资不超35亿元
2026-02-24 - ST人福：招商生科拟收购股份超30%触发要约收购义
2026-02-24 - 人福医药召开2026年工作会议
2026-02-15
消息列表
| 利好 | 股票增发 | 董事会通过 | 2026-02-25 |
| 一般消息 | 重大事项 | 关联交易 | 2026-02-25 |
| 一般消息 | 高管变动 | 个人原因 | 2026-02-24 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-31 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-12-30 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-12-29 |
| 利空 | 上市变动 | 特别处理ST | 2025-12-16 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-08 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-14 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-08-01 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-07-30 |
| 一般消息 | 高管变动 | 退休 | 2025-07-02 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-06-21 |
| 一般消息 | 高管变动 | 个人原因(退休) | 2025-06-09 |
| 一般消息 | 重大事项 | 公司股东股份解冻 | 2025-05-01 |
| 利好 | 分红转增 | 10派3.20元(含税) | 2025-04-29 |
| 一般消息 | 高管变动 | 委员会调整 | 2025-04-22 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 3条 | 0条 | 3条 |
行业面诊股
诊断结果：6.2行业面打败了76%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.02.26","price":"-0.01","value":"-0.81"},{"date":"2026.02.25","price":"0.72","value":"0.87"},{"date":"2026.02.24","price":"0.87","value":"0.55"},{"date":"2026.02.13","price":"-1.26","value":"-0.79"},{"date":"2026.02.12","price":"0.05","value":"-1.10"},{"date":"2026.02.11","price":"0.09","value":"-0.46"},{"date":"2026.02.10","price":"0.13","value":"0.52"},{"date":"2026.02.09","price":"1.41","value":"0.67"},{"date":"2026.02.06","price":"-0.25","value":"0.56"},{"date":"2026.02.05","price":"-0.64","value":"0.23"},{"date":"2026.02.04","price":"0.85","value":"0.76"},{"date":"2026.02.03","price":"1.29","value":"1.56"},{"date":"2026.02.02","price":"-2.48","value":"-2.55"},{"date":"2026.01.30","price":"-0.96","value":"-0.63"},{"date":"2026.01.29","price":"0.16","value":"-0.82"},{"date":"2026.01.28","price":"0.27","value":"-1.60"},{"date":"2026.01.27","price":"0.18","value":"-1.34"},{"date":"2026.01.26","price":"-0.09","value":"0.66"},{"date":"2026.01.23","price":"0.33","value":"1.43"},{"date":"2026.01.22","price":"0.14","value":"-0.07"},{"date":"2026.01.21","price":"0.08","value":"0.37"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 广生堂 | 43.63% | -11.81% | 3.9分 |
| 2 | 海翔药业 | 38.62% | 7.68% | 5.9分 |
| 3 | 科源制药 | 37.06% | 15.32% | 5.5分 |
| 4 | 浙江医药 | 15.77% | 2.12% | 6.2分 |
| 5 | 新和成 | 12.99% | 2.00% | 6.3分 |
| 6 | 润都股份 | 12.96% | -5.80% | 5.0分 |
| 8 | 北陆药业 | 10.22% | -2.05% | 5.1分 |
| 10 | ST人福 | 8.39% | 4.27% | 6.4分 |
| 12 | 东亚药业 | 7.73% | 6.64% | 5.4分 |
| 14 | ST天圣 | 6.43% | 1.15% | 5.8分 |
| 16 | 易明医药 | 4.81% | -0.05% | 5.4分 |
| 18 | 健友股份 | 4.53% | -0.20% | 5.5分 |
| 20 | 美诺华 | 3.68% | 0.52% | 5.6分 |
| 22 | 神奇制药 | 3.35% | -0.31% | 6.2分 |
| 24 | 赛托生物 | 3.32% | -0.47% | 5.6分 |
| 26 | 丰原药业 | 2.91% | 0.45% | 5.8分 |
| 28 | 河化股份 | 2.19% | 1.08% | 6.0分 |
| 30 | 亿帆医药 | 1.79% | 6.94% | 5.4分 |
| 32 | 多瑞医药 | 1.55% | -0.09% | 5.2分 |
| 34 | 亨迪药业 | 1.18% | -0.47% | 4.6分 |
| 36 | 天新药业 | 0.85% | -0.18% | 5.3分 |
| 38 | 西点药业 | 0.67% | -0.76% | 5.5分 |
| 40 | 仙琚制药 | 0.64% | 0.86% | 5.2分 |
| 42 | 津药药业 | 0.47% | -1.17% | 5.0分 |
| 44 | 海森药业 | 0.13% | -1.93% | 4.8分 |
| 46 | *ST三圣 | 0.00% | 0.46% | 5.3分 |
| 48 | 溢多利 | -0.57% | 0.14% | 5.0分 |
| 50 | 拓新药业 | -0.68% | 0.79% | 3.5分 |
| 52 | 复旦张江 | -0.69% | -1.59% | 4.6分 |
| 54 | 鲁抗医药 | -0.87% | -0.33% | 4.2分 |
| 56 | 九典制药 | -0.95% | 0.26% | 4.8分 |
| 58 | 德展健康 | -1.02% | -1.78% | 3.1分 |
| 60 | - | -1.07% | 0.40% | 分 |
| 62 | 誉衡药业 | -1.14% | 0.87% | 5.6分 |
| 64 | 威尔药业 | -1.18% | -1.82% | 5.5分 |
| 66 | 卫信康 | -1.23% | -1.67% | 5.3分 |
| 68 | - | -1.36% | -0.46% | 分 |
| 70 | 普洛药业 | -1.57% | -3.04% | 4.7分 |
| 72 | 宏源药业 | -1.83% | 0.87% | 5.9分 |
| 74 | 东北制药 | -1.89% | -0.95% | 5.2分 |
| 76 | 海普瑞 | -2.03% | -2.90% | 4.7分 |
| 78 | 宣泰医药 | -2.17% | -0.58% | 4.1分 |
| 80 | 小方制药 | -2.42% | -1.52% | 4.3分 |
| 82 | 北大医药 | -2.49% | -1.26% | 4.7分 |
| 84 | 盟科药业 | -2.79% | -1.88% | 4.6分 |
| 86 | 莎普爱思 | -2.99% | -1.19% | 4.5分 |
| 88 | 莱美药业 | -3.24% | 1.40% | 4.1分 |
| 90 | 复星医药 | -3.25% | -2.64% | 4.7分 |
| 92 | 灵康药业 | -3.56% | -2.54% | 4.7分 |
| 94 | 民生健康 | -4.06% | -2.38% | 4.5分 |
| 96 | 千红制药 | -4.29% | -1.39% | 4.5分 |
| 98 | 圣诺生物 | -4.47% | -0.10% | 5.1分 |
| 100 | 贝达药业 | -4.52% | -2.48% | 4.6分 |
| 102 | 泽璟制药 | -4.98% | -13.74% | 3.6分 |
| 104 | 亚太药业 | -5.20% | -2.81% | 4.5分 |
| 106 | 金陵药业 | -5.27% | -1.69% | 4.9分 |
| 108 | 恒瑞医药 | -5.62% | -3.70% | 4.5分 |
| 110 | 辰欣药业 | -5.80% | -0.34% | 4.6分 |
| 112 | 华海药业 | -6.10% | -2.36% | 4.0分 |
| 114 | 华东医药 | -6.25% | -2.51% | 5.1分 |
| 116 | 富士莱 | -6.27% | -0.11% | 6.0分 |
| 118 | 永安药业 | -6.43% | -0.34% | 4.3分 |
| 120 | - | -6.52% | -2.27% | 分 |
| 122 | 信立泰 | -6.64% | -8.47% | 5.5分 |
| 124 | 键凯科技 | -6.79% | -1.03% | 5.9分 |
| 126 | 微芯生物 | -7.38% | 2.95% | 5.1分 |
| 128 | 立方制药 | -8.28% | -4.41% | 5.4分 |
| 130 | 海思科 | -9.14% | -4.84% | 5.6分 |
| 132 | 海辰药业 | -9.18% | 3.60% | 4.8分 |
| 134 | 上海谊众 | -9.30% | -6.28% | 5.1分 |
| 136 | 福元医药 | -9.96% | -7.05% | 4.4分 |
| 138 | 海创药业 | -10.37% | -3.19% | 4.3分 |
| 140 | 海南海药 | -10.73% | -4.92% | 4.1分 |
| 142 | 博瑞医药 | -12.06% | -4.92% | 3.4分 |
| 144 | 通化金马 | -12.57% | 0.30% | 4.7分 |
| 146 | ST诺泰 | -14.08% | -7.08% | 4.4分 |
| 148 | 常山药业 | -14.57% | 2.01% | 4.0分 |
| 150 | 奥锐特 | -14.86% | -1.60% | 4.7分 |
| 152 | 新诺威 | -15.04% | -5.92% | 4.4分 |
| 154 | 迪哲医药 | -18.58% | -8.03% | 4.0分 |
| 156 | 益方生物 | -25.03% | -9.19% | 3.6分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 29/218 ， 75/218。
[{"date":"2025-09-30","value":"9.24","vol":"1.51"},{"date":"2025-06-30","value":"6.42","vol":"1.23"},{"date":"2025-03-31","value":"3.02","vol":"-0.14"},{"date":"2024-12-31","value":"7.67","vol":"19.62"},{"date":"2024-09-30","value":"9.11","vol":"4.62"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
9.24 | 6.42 | 3.02 | 7.67 | 9.11 |
| 行业(%) | 1.51 | 1.23 | -0.14 | 19.62 | 4.62 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"47.95","vol":"49.36"},{"date":"2025-06-30","value":"48.18","vol":"49.33"},{"date":"2025-03-31","value":"48.56","vol":"49.14"},{"date":"2024-12-31","value":"44.55","vol":"50.78"},{"date":"2024-09-30","value":"46.76","vol":"50.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
47.95 | 48.18 | 48.56 | 44.55 | 46.76 |
| 行业(%) | 49.36 | 49.33 | 49.14 | 50.78 | 50.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 95/218 ， 62/218。
[{"date":"2025-09-30","value":"-6.58","vol":"142.98"},{"date":"2025-06-30","value":"-6.20","vol":"79.25"},{"date":"2025-03-31","value":"-3.61","vol":"-0.67"},{"date":"2024-12-31","value":"3.71","vol":"18.07"},{"date":"2024-09-30","value":"5.70","vol":"45.94"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-6.58 | -6.20 | -3.61 | 3.71 | 5.70 |
| 行业(%) | 142.98 | 79.25 | -0.67 | 18.07 | 45.94 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"6.22","vol":"-3.26"},{"date":"2025-06-30","value":"3.92","vol":"58.57"},{"date":"2025-03-31","value":"11.09","vol":"-11.22"},{"date":"2024-12-31","value":"-37.70","vol":"-22.02"},{"date":"2024-09-30","value":"-10.12","vol":"-34.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
6.22 | 3.92 | 11.09 | -37.70 | -10.12 |
| 行业(%) | -3.26 | 58.57 | -11.22 | -22.02 | -34.66 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 20/218 ， 30/218。
[{"date":"2025-09-30","value":"0.49","vol":"0.31"},{"date":"2025-06-30","value":"0.33","vol":"0.21"},{"date":"2025-03-31","value":"0.17","vol":"0.10"},{"date":"2024-12-31","value":"0.70","vol":"0.43"},{"date":"2024-09-30","value":"0.52","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.49 | 0.33 | 0.17 | 0.70 | 0.52 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.65","vol":"1.94"},{"date":"2025-06-30","value":"1.78","vol":"1.30"},{"date":"2025-03-31","value":"0.90","vol":"0.66"},{"date":"2024-12-31","value":"3.93","vol":"3.19"},{"date":"2024-09-30","value":"2.70","vol":"2.12"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.65 | 1.78 | 0.90 | 3.93 | 2.70 |
| 行业(次) | 1.94 | 1.30 | 0.66 | 3.19 | 2.12 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"13.57","vol":"4.43"},{"date":"2025-06-30","value":"20.17","vol":"2.74"},{"date":"2025-03-31","value":"-5.49","vol":"-26.98"},{"date":"2024-12-31","value":"10.67","vol":"-373.99"},{"date":"2024-09-30","value":"10.30","vol":"-9.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 13.57 | 20.17 | -5.49 | 10.67 | 10.30 |
| 行业 | 4.43 | 2.74 | -26.98 | -373.99 | -9.47 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.74","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.98","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.74 | - | 0.98 | - |
| 行业 | 0.00 | 1.73 | 0.00 | 2.00 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 22/218 ， 38/218。
[{"date":"2025-09-30","value":"1.69","vol":"3.50"},{"date":"2025-06-30","value":"1.54","vol":"3.69"},{"date":"2025-03-31","value":"1.49","vol":"3.61"},{"date":"2024-12-31","value":"1.49","vol":"3.36"},{"date":"2024-09-30","value":"1.49","vol":"3.67"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.69 | 1.54 | 1.49 | 1.49 | 1.49 |
| 行业 | 3.50 | 3.69 | 3.61 | 3.36 | 3.67 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.34","vol":"2.75"},{"date":"2025-06-30","value":"1.24","vol":"2.90"},{"date":"2025-03-31","value":"1.19","vol":"2.83"},{"date":"2024-12-31","value":"1.17","vol":"2.65"},{"date":"2024-09-30","value":"1.15","vol":"2.93"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.34 | 1.24 | 1.19 | 1.17 | 1.15 |
| 行业 | 2.75 | 2.90 | 2.83 | 2.65 | 2.93 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 38/218 ， 44/218。
[{"date":"2025-09-30","value":"40.53","vol":"33.63"},{"date":"2025-06-30","value":"43.00","vol":"33.66"},{"date":"2025-03-31","value":"42.59","vol":"33.90"},{"date":"2024-12-31","value":"43.32","vol":"34.07"},{"date":"2024-09-30","value":"43.72","vol":"32.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
40.53 | 43.00 | 42.59 | 43.32 | 43.72 |
| 行业(%) | 33.63 | 33.66 | 33.90 | 34.07 | 32.87 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.79","vol":"0.94"},{"date":"2025-06-30","value":"0.88","vol":"0.88"},{"date":"2025-03-31","value":"0.87","vol":"1.47"},{"date":"2024-12-31","value":"0.90","vol":"0.84"},{"date":"2024-09-30","value":"0.91","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.79 | 0.88 | 0.87 | 0.90 | 0.91 |
| 行业(%) | 0.94 | 0.88 | 1.47 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"13.17","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"24.84","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"21.34","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"13.30","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"21.35","blueLineValue":"1.31","type":"YC"}]